Ethical Medicines vs. Generic Medicines: What the Difference Means for Wholesalers
If you are a pharmaceutical wholesaler — whether domestic or international — one of the most fundamental distinctions in Indian pharma trade is the difference between ethical (branded) medicines and generic medicines. The two categories operate under different commercial dynamics, margin structures, and procurement logic.
This post explains the distinction and what it means practically for wholesalers making sourcing decisions.
---
Defining the Terms
Ethical (Branded) Medicines In Indian pharmaceutical trade, "ethical" medicine traditionally means a product that is: - Manufactured and marketed by a specific company under their proprietary brand name - Promoted through the "ethical channel" — that is, directly to prescribers (doctors) rather than through consumer advertising - Sold under that brand name across the supply chainThe brand creates a commercial identity that buyers, prescribers, and patients associate with a specific manufacturer. Brand equity is the key commercial differentiator.
Generic Medicines A generic medicine contains the same active pharmaceutical ingredient (API) in the same strength and form as a reference (often branded) product. It is sold either: - Under the molecule's International Non-proprietary Name (INN) — e.g., "Amoxicillin 500mg capsules" - Or under a different brand name (a "branded generic" — common in Indian pharma)The key point is that the molecule is off-patent, so multiple manufacturers can produce it without intellectual property restrictions. Competition drives prices lower.
---
Commercial Differences: Margin and Pricing
For wholesalers, the economic models differ significantly:
Ethical medicines: - Price is set by the innovator/brand company; traders and distributors work within the company's defined margin structure (PTR — Price to Retailer, PTS — Price to Stockist) - Margins are typically fixed and clearly defined by the pharmaceutical company - For products under DPCO (Drug Price Control Order), the Maximum Retail Price (MRP) is government-regulated - Brand loyalty drives offtake — a wholesaler carrying a well-prescribed brand benefits from consistent demand tied to prescriber habits Generic medicines: - Pricing is competitive across manufacturers; a wholesaler can negotiate based on volume and manufacturer relationship - Margins can be higher (more negotiation room) but require active market development — there is no brand-led prescription demand to rely on - Particularly relevant for international markets where the buyer is sourcing by INN for a formulary or tender, not by brand Branded generics (a significant Indian market category): - Indian pharma has a strong tradition of "branded generics" — generic molecules sold under a manufacturer's own brand name - These combine some of the margin predictability of branded products with the price competitiveness of generics - Widely prescribed in India; also relevant for export to markets where Indian branded generics have established prescriber recognition---
Regulatory Considerations for Each Category
Both ethical and generic medicines sold in India must meet standards under the Drugs & Cosmetics Act, 1940 and the Drugs Rules, 1945. The distinction is commercial, not a quality hierarchy — a well-manufactured generic meeting Indian Pharmacopoeia (IP) standards is not inferior to a branded product on quality grounds.
For export, the relevant quality standards depend on the importing country's regulatory requirements: - WHO-GMP certification from the manufacturer is a widely accepted quality benchmark internationally - EU-GMP or US FDA approval is required for exporting to European or US markets - Many African and Asian regulatory authorities accept WHO-GMP as a quality threshold
As a wholesaler sourcing from a trader like Bharat Medex, you should ask for the manufacturer's current GMP certificate for any product in your procurement, regardless of whether it is ethical or generic.
---
Which Category Suits Your Business?
Source ethical/branded medicines if: - Your buyers/clients specify brand names (either by prescriber habit or patient demand) - You are serving markets with strong brand loyalty in specific therapeutic categories - You need the predictability of a defined company margin structure Source generic medicines if: - You are serving tender or formulary-based procurement (where INN is specified, not brand) - Price competitiveness is the primary driver for your market (common in Africa, Southeast Asia, parts of Latin America) - You are building a broad portfolio across multiple manufacturers at better margins Combine both if: - Your customer base includes both brand-loyal pharmacies/hospitals and price-sensitive formulary buyers — a mixed portfolio gives you coverage across both demand types---
Bharat Medex: Both Categories, One Contact
Bharat Medex covers both ethical (branded) and generic medicines, as well as surgical items — meaning wholesalers with mixed requirements can discuss both segments in a single sourcing conversation. We are based in Nagpur and have been active in pharmaceutical trade for over 19 years.
Contact us to discuss your product requirements and we will advise on availability, pricing, and documentation.
0 comments